EuroIntervention PCRonline - Connecting with the community

Christian W. Hamm

25 articles

Clinical Restenosis and its Predictors after Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds: Results from the GABI-R Registry

EuroIntervention 2017; just accepted article published in June 2017

Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

EuroIntervention 2017;13:69-77 published online January 2017

Published in Volume 13 Number 1, May 2017

Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI)

EuroIntervention 2017; just accepted article published in April 2017

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015

Published in Volume 12 Number 10, November 2016

Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction

EuroIntervention 2015;11:204 published online ahead of print February 2015

Published in Volume 11 Number 2, June 2015

2014 ESC/EACTS Guidelines on myocardial revascularization

EuroIntervention 2015;10:1024-1094  published online ahead of print September 2014

Published in Volume 10 Number 9, January 2015

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

EuroIntervention 2014;10:850-859

Published in Volume 10 Number 7, November 2014

Predictors of recurrent stroke after percutaneous closure of patent foramen ovale

EuroIntervention 2014;9:1418-1422

Published in Volume 9 Number 12, April 2014

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

EuroIntervention 2011;7:442-448

Published in Volume 7 Number 4, August 2011

Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI

EuroIntervention 2011;7:437-441

Published in Volume 7 Number 4, August 2011

Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry

EuroIntervention 2011;7:201-208

Published in Volume 7 Number 2, June 2011

Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-eluting stents: one-year clinical outcomes from the ProEnCy registry

Published in Volume 7 Supplement M, May 2011

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

EuroIntervention 2010;6:336-342 - DOI10.4244/EIJV6I3A56

Published in Volume 6 Number 3, August 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroIntervention 2010;5:962-967

Published in Volume 5 Number 8, April 2010

Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)

EuroIntervention 2009;5:190:196

Published in Volume 5 Number 2, June 2009

Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions

Published in Volume 5 Supplement E, May 2009

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

EuroInterv.2009;4:492-501

Published in Volume 4 Number 4, January 2009

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroInterv.2008;3:450-459

Published in Volume 3 Number 4, January 2008

Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design

EuroIntervention 2007;3:371-380 - DOI10.4244/EIJV3I3A67

Published in Volume 3 Number 3, November 2007

A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy

EuroIntervention 2007;3:228-234 - DOI10.4244/EIJV3I2A39

Published in Volume 3 Number 2, August 2007

Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)

EuroInterv.2007;3:206-212

Published in Volume 3 Number 2, August 2007

The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation

EuroIntervention 2007;2:459-466 - DOI10.4244/EIJV2I4A82

Published in Volume 2 Number 4, February 2007

One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings
(The SPIRIT FIRST Trial)

EuroInterv.2005;1:266-272

Published in Volume 1 Number 3, November 2005

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions

EuroIntervention 2005;1:147-156 - DOI10.4244/EIJV1I2A25

Published in Volume 1 Number 2, August 2005

A randomized comparison of a durable polymer

EuroIntervention 2005;1:58-65 - DOI10.4244/EIJV1I1A07

Published in Volume 1 Number 1, May 2005